IDEAS home Printed from https://ideas.repec.org/a/ces/ifosdt/v63y2010i16p03-21.html
   My bibliography  Save this article

Gesundheitsreform 2010: Einstieg in den Systemwechsel?

Author

Listed:
  • Philipp Rösler
  • Jochen Pimpertz
  • Friedrich Breyer
  • Wolfgang Greiner
  • Gebhard Kirchgässer
  • Jürgen Wasem

Abstract

Im Herbst soll im Bundestag eine Reform der GKV verabschiedet werden und zum 1. Januar 2011 in Kraft treten. Philipp Rösler, Bundesgesundheitsminister, unterstreicht, dass die Reform den Einstieg in den Systemwechsel bedeutet: Denn mit der Festschreibung des prozentualen Beitragssatzes und der Weiterentwicklung der Zusatzbeiträge werden die Einkommensabhängigkeit der Finanzierung des Gesundheitssystems vermindert und ein transparentes Preissignal geboten, die Krankenkassen erhalten Beitragsautonomie. Jochen Pimpertz, Institut der deutschen Wirtschaft Köln, ist nicht so optimistisch. Seiner Ansicht nach ist das Reformmodell enttäuschend. Statt einer Abkehr von der einkommensabhängigen Beitragsfinanzierung steige zunächst nur der Beitragssatz. Mit dieser Anhebung des Beitragssatzes werden sowohl die Fehlanreize als auch die Fehlverteilungen infolge der Beitragsfinanzierung ausgedehnt. Friedrich Breyer, Universität Konstanz, vermisst ebenfalls die angekündigte weitreichende Reform des Finanzierungsmodells. Es gehe stattdessen in der Hauptsache um die Abwendung eines Defizits der Krankenkassen. Auch kehre nicht mehr Wettbewerb ins deutsche Gesundheitssystem ein. Wolfgang Greiner, Universität Bielefeld, sieht weiterhin Reformbedarf: »Wie in den vergangenen Jahren ist nach der Reform vor der Reform und man kann der Gesundheitspolitik nur raten, die Ausgabendynamik nicht nur durch dirigistische Eingriffe in die Preisstruktur, sondern auch durch sich selbst regulierende wettbewerbliche Findungsprozesse ablaufen zu lassen.« Gebhard Kirchgässner, Universität St. Gallen, kritisiert u.a. den Anstieg des Arbeitnehmerbeitrags. Damit werden die Krankenkassenprämien nicht von den Löhnen abgekoppelt, sondern die Differenz zwischen Brutto- und Nettolohn steige noch. Und auch Jürgen Wasem, Universität Duisburg-Essen, sieht vor allem eine »triste Kostendämpfung statt struktureller Reformen«.

Suggested Citation

  • Philipp Rösler & Jochen Pimpertz & Friedrich Breyer & Wolfgang Greiner & Gebhard Kirchgässer & Jürgen Wasem, 2010. "Gesundheitsreform 2010: Einstieg in den Systemwechsel?," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 63(16), pages 03-21, August.
  • Handle: RePEc:ces:ifosdt:v:63:y:2010:i:16:p:03-21
    as

    Download full text from publisher

    File URL: https://www.ifo.de/DocDL/ifosd_2010_16_1.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Hartwig, Jochen, 2008. "What drives health care expenditure?--Baumol's model of 'unbalanced growth' revisited," Journal of Health Economics, Elsevier, vol. 27(3), pages 603-623, May.
    2. Stefan Felder, 2006. "Lebenserwartung, medizinischer Fortschritt und Gesundheitsausgaben: Theorie und Empirie," Perspektiven der Wirtschaftspolitik, Verein für Socialpolitik, vol. 7(s1), pages 49-73, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Malmaeus, J. Mikael & Alfredsson, Eva C., 2017. "Potential Consequences on the Economy of Low or No Growth - Short and Long Term Perspectives," Ecological Economics, Elsevier, vol. 134(C), pages 57-64.
    2. Felipa de Mello-Sampayo & Sofia de Sousa-Vale, 2014. "Financing Health Care Expenditure in the OECD Countries: Evidence from a Heterogeneous, Cross-Sectional Dependent Panel," Panoeconomicus, Savez ekonomista Vojvodine, Novi Sad, Serbia, vol. 61(2), pages 207-225, March.
    3. Akinwande Atanda & W. Robert Reed, 2019. "Not Evidence for Baumol’s Cost Disease," Working Papers in Economics 19/05, University of Canterbury, Department of Economics and Finance.
    4. Tomasz Rokicki & Aleksandra Perkowska & Marcin Ratajczak, 2020. "Differentiation in Healthcare Financing in EU Countries," Sustainability, MDPI, vol. 13(1), pages 1-17, December.
    5. Bates, Laurie & Santerre, Rexford, 2013. "Is the U.S. Private Education Sector Infected by Baumol’s Cost Disease? Evidence from the 50 States," MPRA Paper 52300, University Library of Munich, Germany.
    6. Jochen Kurt Hartwig, 2010. "Baumol's Diseases," KOF Working papers 10-250, KOF Swiss Economic Institute, ETH Zurich.
    7. repec:hum:wpaper:sfb649dp2008-031 is not listed on IDEAS
    8. Maik T. Schneider & Ralph Winkler, 2021. "Growth and Welfare under Endogenous Lifetimes," Scandinavian Journal of Economics, Wiley Blackwell, vol. 123(4), pages 1339-1384, October.
    9. Y. TAMSAMANI, Yasser, 2017. "L’évolution des dépenses de santé au Maroc : une analyse des déterminants démographiques et macro-économiques [The Evolution of the Health Expenditures in Morocco: A Demographics and Macroeconomics," MPRA Paper 83996, University Library of Munich, Germany, revised 18 Jan 2018.
    10. Mehlum, Halvor & Torvik, Ragnar & Valente, Simone, 2016. "The savings multiplier," Journal of Monetary Economics, Elsevier, vol. 83(C), pages 90-105.
    11. Yu, Xuan & Li, Cheng & Shi, Yuhua & Yu, Min, 2010. "Pharmaceutical supply chain in China: Current issues and implications for health system reform," Health Policy, Elsevier, vol. 97(1), pages 8-15, September.
    12. Abdul Wahab, Abdul Azeez Oluwanisola & Kefeli, Zurina & Hashim, Nurhazirah, 2018. "Investigating The Dynamic Effect of Healthcare Expenditure and Education Expenditure On Economic Growth in Organisation of Islamic Countries (OIC)," MPRA Paper 90338, University Library of Munich, Germany, revised 19 Oct 2018.
    13. Ekaterini Panopoulou & Theologos Pantelidis, 2012. "Convergence in per capita health expenditures and health outcomes in the OECD countries," Applied Economics, Taylor & Francis Journals, vol. 44(30), pages 3909-3920, October.
    14. Colombier, Carsten, 2012. "Drivers of health care expenditure: Does Baumol's cost disease loom large?," FiFo Discussion Papers - Finanzwissenschaftliche Diskussionsbeiträge 12-5, University of Cologne, FiFo Institute for Public Economics.
    15. Stefan Felder & Andreas Werblow, 2009. "The Marginal Cost of Saving a Life in Health Care: Age, Gender and Regional Differences in Switzerland," Swiss Journal of Economics and Statistics (SJES), Swiss Society of Economics and Statistics (SSES), vol. 145(II), pages 137-153, June.
    16. Badi H. Baltagi & Raffaele Lagravinese & Francesco Moscone & Elisa Tosetti, 2017. "Health Care Expenditure and Income: A Global Perspective," Health Economics, John Wiley & Sons, Ltd., vol. 26(7), pages 863-874, July.
    17. Felipa de Mello-Sampayo & Sofia de Sousa-Vale, 2014. "Financing Health Care Expenditure in the OECD Countries: Evidence from a Heterogeneous, Cross-Sectional Dependent Panel," Panoeconomicus, Savez ekonomista Vojvodine, Novi Sad, Serbia, vol. 61(2), pages 207-225.
    18. Isabel Casas & Jiti Gao & Bin Peng & Shangyu Xie, 2021. "Time‐varying income elasticities of healthcare expenditure for the OECD and Eurozone," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 36(3), pages 328-345, April.
    19. Zapji Ymélé Aimé Philombe, 2022. "Interest Charges and the “Said†Ageing-related Expenditures: A Study of OECD Countries," International Journal of Business and Economic Sciences Applied Research (IJBESAR), Democritus University of Thrace (DUTH), Kavala Campus, Greece, vol. 15(3), pages 7-23, December.
    20. Jörg Mahlich & Arne Bartol & Srirangan Dheban, 2021. "Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis," Health Economics Review, Springer, vol. 11(1), pages 1-10, December.
    21. Thomas Barnay & Olivier Damette, 2012. "What drives Health Care Expenditure in France since 1950? A time-series study with structural breaks and nonlinearity approaches," Working Papers halshs-00856117, HAL.

    More about this item

    Keywords

    Gesundheitswesen; Gesundheitsversorgung; Gesetzliche Krankenversicherung; Gesundheitsreform; Deutschland;
    All these keywords.

    JEL classification:

    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ces:ifosdt:v:63:y:2010:i:16:p:03-21. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Klaus Wohlrabe (email available below). General contact details of provider: https://edirc.repec.org/data/ifooode.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.